Inflammatix IPO

inflammatix.com

Inflammatix uses molecular diagnostics to read the patient’s immune system to deliver rapid results that improve patient care and reduce major public health burdens.

Founded2016
Total Funding to Date$160.26MM
Register for Details

For more details on financing and valuation for Inflammatix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Inflammatix Ticker Symbol

Inflammatix does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Inflammatix Stock Price

The stock price for Inflammatix will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Inflammatix Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/16/2021 Series D $107.74MM raised $XXX.XX $XXX.XX
1/10/2020 Series C $34.1MM raised $XXX.XX $XXX.XX
10/18/2018 Series B $14.29MM raised $XXX.XX $XXX.XX
3/17/2017 Series A $4.12MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Inflammatix in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector